Filing Details
- Accession Number:
- 0001181431-12-060932
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-28 19:35:50
- Reporting Period:
- 2012-11-26
- Filing Date:
- 2012-11-28
- Accepted Time:
- 2012-11-28 19:35:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1001233 | Sangamo Biosciences Inc | SGMO | Biological Products, (No Disgnostic Substances) (2836) | 680359556 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202278 | G Dale Ando | C/O Sangamo Biosciences Inc. Point Richmond Tech Cntr, 501 Canal Blvd Richmond CA 94804 | Vp, Therapeutic Dev. & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-11-26 | 4,736 | $5.33 | 55,798 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-11-27 | 15,000 | $3.61 | 70,798 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-27 | 15,000 | $5.60 | 55,798 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| 15000 | Employee Stock Option (Right to Buy) | Disposition | 2012-11-27 | 15,000 | $0.00 | 0 | $3.61 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 50,800 | 2014-08-01 | No | 4 | M | Direct |
Footnotes
- The sales resported in this Form 4 were effected pursauant to the Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2012, amended on September 12, 2012.
- The price reported in Column 4 is a weighted average price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.31 to #53501, inclusive. The Reporting person undertakes to provide to Sangamo Biosciences Inc., any security holder of separate price within the manages set forth in footnotes (2) and (3) to this Form 4.
- Includes 2,000 shares acquired by Reporting Person on October 31, 2012 under the Issuer's Employee Stock Purchase Plan.
- All shares underlying this option are vested and immediatedly exercisalbe.
Billionaire Hedge Funds
